Institutional Ownership Milestone Pharmaceuticals Inc. (MIST)
This table provides information about the institutional ownership of Milestone Pharmaceuticals Inc. (MIST). We have compiled data on the 44 institutions that hold shares in the stock, with a total of 28.6 Million shares, which have been reported (via 13F filing form) to have a value of $52.9 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,971,344
shares
|
$9.2 Million
0.0% of portfolio
|
Q1 2024
Added 51.99%
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
3,256,102
shares
|
$6.02 Million
0.08% of portfolio
|
Q1 2023
Reduced 24.54%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
2,778,525
shares
|
$5.14 Million
0.0% of portfolio
|
Q3 2024
Added 1.04%
|
|
Alta Fundamental Advisers LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
2,658,589
shares
|
$4.92 Million
1.79% of portfolio
|
Q2 2024
Added 12.12%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
2,061,522
shares
|
$3.81 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.0%
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
2,000,000
shares
|
$3.7 Million
0.07% of portfolio
|
Q1 2024
New holding
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Nov 14, 2024 Q3 2024 |
1,750,000
shares
|
$3.24 Million
0.16% of portfolio
|
Q1 2024
New holding
|
|
Lion Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,654,154
shares
|
$3.06 Million
6.75% of portfolio
|
Q3 2024
Reduced 29.32%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,353,067
shares
|
$2.5 Million
0.0% of portfolio
|
Q3 2023
Added 89.11%
|
|
Bleichroeder LP
New York, NY |
Nov 13, 2024 Q3 2024 |
1,326,085
shares
|
$2.45 Million
0.68% of portfolio
|
Q4 2022
Added 158.75%
|
|
Bml Capital Management, LLC
Zionsville, IN |
Nov 05, 2024 Q3 2024 |
1,136,091
shares
|
$2.1 Million
1.02% of portfolio
|
Q3 2024
Added 3.01%
|
|
Stonepine Capital Management, LLC
Bend, OR |
Nov 13, 2024 Q3 2024 |
999,790
shares
|
$1.85 Million
0.96% of portfolio
|
Q3 2024
Reduced 19.32%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
918,312
shares
|
$1.7 Million
0.0% of portfolio
|
Q3 2024
Added 10.82%
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
466,019
shares
|
$862,135
0.12% of portfolio
|
Q1 2024
Added 0.69%
|
|
Altium Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
440,000
shares
|
$814,000
0.24% of portfolio
|
Q3 2024
Reduced 56.54%
|
|
Boxer Capital, LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
309,007
shares
|
$571,662
0.02% of portfolio
|
Q4 2023
Reduced 55.78%
|
|
Envestnet Asset Management Inc
|
Nov 06, 2024 Q3 2024 |
70,590
shares
|
$130,591
0.0% of portfolio
|
Q3 2024
Added 18.59%
|
|
Ancora Advisors, LLC
Cleveland, OH |
Nov 14, 2024 Q3 2024 |
60,000
shares
|
$111,000
0.0% of portfolio
|
Q1 2024
Added 20.0%
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
54,245
shares
|
$100,353
0.0% of portfolio
|
Q3 2024
Reduced 0.8%
|
|
Atria Investments LLC
Charlotte, NC |
Nov 01, 2024 Q3 2024 |
40,421
shares
|
$74,778
0.0% of portfolio
|
Q3 2024
Added 44.41%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
39,450
shares
|
$72,982
0.0% of portfolio
|
Q1 2024
Reduced 46.48%
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
30,779
shares
|
$56,941
0.0% of portfolio
|
Q1 2024
Added 11.57%
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2024 Q3 2024 |
27,931
shares
|
$51,672
0.01% of portfolio
|
Q3 2024
Reduced 86.2%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
27,336
shares
|
$50,571
0.0% of portfolio
|
Q3 2024
Reduced 1.61%
|
|
Cetera Investment Advisers
Schaumburg, IL |
Nov 13, 2024 Q3 2024 |
24,671
shares
|
$45,641
0.0% of portfolio
|
Q3 2024
Added 19.25%
|